Results 51 to 60 of about 146,743 (148)

t(11;14) multiple myeloma patient: minimal residual disease after 10 years of follow-up - a case report

Haematologica
Not available.
Sarah Decheiver, Anais Schavgoulidze, Sabrina Maheo, Pierre-Adrien Vion, Olivier Lucidarme, Jill Corre, Laurent Garderet   +6 more
doaj   +1 more source

Multiple myeloma

BMJ, 2013
Dean, Smith, Kwee, Yong
openaire   +4 more sources

I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients

Blood Cancer Journal, 2022
Sarvarinder K. Gill, Rashmi Unawane, Shuqi Wang, Jaeil Ahn, Adolfo Aleman, David S. Siegel, David H. Vesole, Harsh Parmar, Pooja Phull, Noa Biran   +9 more
doaj   +1 more source

Dissecting immunophenotypic diversity in multiple myeloma via mass cytometry: a call for harmonized gating strategies

Frontiers in Immunology
Plasma cell disorders present challenges in phenotypic determination, as they range from monoclonality of plasma cells to multiple myeloma and plasma cell leukemia.
Mahmoud Singer, Milad Moloudizargari, Milad Moloudizargari, James Sanchez, Flavia Pichiorri, Flavia Pichiorri   +5 more
doaj   +1 more source

Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma

Blood Cancer Journal
The main objective of this multi-institutional study is to understand the effect of primary intravenous immunoglobulin (IVIG) replacement on clinical outcomes in recipients of BCMA-directed bispecific antibody (bsAb), where infection remains an important
Meera Mohan, Aniko Szabo, Heloise Cheruvalath, Anna Clennon, Vineel Bhatlapenumarthi, Anannya Patwari, Metodi Balev, Divaya Bhutani, Asis Shrestha, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Anup Trikannad, Sruthi Vellanki, Samer Al-Hadidi, Suzanne Lentzsch, Frits van Rhee, Aishee Bag, Anita D’Souza, Nishi Shah, Rajshekhar Chakraborty, Mansi R. Shah, Carolina Schinke   +22 more
doaj   +1 more source

Multiple myeloma [PDF]

Clinical Medicine, 2001
D, Samson, C, Singer
openaire   +2 more sources

Smoldering multiple myeloma: special considerations surrounding treatment on versus off clinical trials

Haematologica, 2014
Elisabet E Manasanch, Neha Korde, Sham Mailankody, Nishant Tageja, Manisha Bhutani, Mark Roschewski, Ola Landgren   +6 more
doaj   +1 more source

Multiple myeloma: an overview of drug therapies and supportive care. [PDF]

Aust Prescr
Hocking J.
europepmc   +1 more source

Dynamic Prediction of Survival Outcomes in Multiple Myeloma. [PDF]

Cancers (Basel)
Quek K, Lee CH, Zhang Y, McClure BJ, Chen R, Scott HS, Vandyke K, Zannettino ACW, Kok CH.   +8 more
europepmc   +1 more source

PHLPP2 expression and its clinical significance in multiple myeloma. [PDF]

Mol Clin Oncol
Li J, Jiang Y, Chen G.
europepmc   +1 more source